Cargando…

Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis

Patients with ulcerative colitis (UC) have an altered gut microbiota composition, but the microbial relationship to disease activity needs to be further elucidated. Therefore, temporal dynamics of the fecal microbial community during remission and flare was determined. Fecal samples were collected a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Öhman, Lena, Lasson, Anders, Strömbeck, Anna, Isaksson, Stefan, Hesselmar, Marcus, Simrén, Magnus, Strid, Hans, Magnusson, Maria K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060394/ https://www.ncbi.nlm.nih.gov/pubmed/33883600 http://dx.doi.org/10.1038/s41598-021-87973-7

Ejemplares similares

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
por: Strömbeck, Anna, et al.
Publicado: (2020)

Health-related quality of life in patients with long-standing ulcerative colitis in remission
por: Mavroudis, Georgios, et al.
Publicado: (2022)

Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission
por: Maasfeh, Lujain, et al.
Publicado: (2021)

Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease
por: Mavroudis, Georgios, et al.
Publicado: (2019)

Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms
por: Moraes, Luiza, et al.
Publicado: (2020)

The Anti-inflammatory Immune Regulation Induced by Butyrate Is Impaired in Inflamed Intestinal Mucosa from Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2019)

Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids
por: Holst, Luiza Moraes, et al.
Publicado: (2022)

A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
por: Klingberg, Eva, et al.
Publicado: (2019)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
por: Iribarren, Cristina, et al.
Publicado: (2022)

Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis
por: Wenzel, Ulf A., et al.
Publicado: (2014)

Impaired Butyrate Induced Regulation of T Cell Surface Expression of CTLA-4 in Patients with Ulcerative Colitis
por: Magnusson, Maria K., et al.
Publicado: (2021)

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
por: Wills, Edgar S., et al.
Publicado: (2014)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
por: Moraes Holst, Luiza, et al.
Publicado: (2022)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial
por: Lahtinen, Perttu, et al.
Publicado: (2023)

The Clinical and Steroid-Free Remission of Fecal Microbiota Transplantation to Patients with Ulcerative Colitis: A Meta-Analysis
por: Lam, Wai Ching, et al.
Publicado: (2019)

The Distinguishing Bacterial Features From Active and Remission Stages of Ulcerative Colitis Revealed by Paired Fecal Metagenomes
por: Zhu, Ran, et al.
Publicado: (2022)

Fecal microbiota transplantation induces remission of infantile allergic colitis through gut microbiota re-establishment
por: Liu, Sheng-Xuan, et al.
Publicado: (2017)

Low-complexity microbiota in the duodenum of children with newly diagnosed ulcerative colitis
por: Sjöberg, Fei, et al.
Publicado: (2017)

Ethnicity Associated Microbial and Metabonomic Profiling in Newly Diagnosed Ulcerative Colitis
por: Misra, Ravi, et al.
Publicado: (2022)

Newly Diagnosed Ulcerative Colitis in the Third Trimester: A Case Report
por: Rodriguez, Arley K, et al.
Publicado: (2023)

Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects
por: Sundin, Johanna, et al.
Publicado: (2018)

Fecal microbiota in pouchitis and ulcerative colitis
por: Li, Kai-Yu, et al.
Publicado: (2016)

Fecal leukocyte in the diagnosis of ulcerative colitis
por: Saraya, Takeshi, et al.
Publicado: (2013)

Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation
por: Chen, Qiongyun, et al.
Publicado: (2023)

Changes in fecal metabolic and lipidomic features by anti-TNF treatment and prediction of clinical remission in patients with ulcerative colitis
por: Kim, Seok-Young, et al.
Publicado: (2023)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis
por: Tokarz, Rafal, et al.
Publicado: (2019)

Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis
por: Kadenczki, Orsolya, et al.
Publicado: (2022)

A systematic review and meta-analysis of artificial intelligence-diagnosed endoscopic remission in ulcerative colitis
por: Lv, Bing, et al.
Publicado: (2023)

Effects of the long-term storage of human fecal microbiota samples collected in RNAlater
por: Tap, Julien, et al.
Publicado: (2019)

Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
por: Yamamoto, Takayuki, et al.
Publicado: (2018)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase
por: Sakurai, Toshiyuki, et al.
Publicado: (2022)

Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite
por: Ishida, Natsuki, et al.
Publicado: (2022)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p84l057mgpghmmg5qaue8pnu4s